Missed the Congress ? NO Problem

Prof. Xinmin Li

David Geffen School of Medicine, University of California at Los Angels, LA, USA

About this speaker

Xinmin Li earned his M.S. in quantitative genetics in China and PhD in molecular genetics at the University of Nottingham in the United Kingdom. After he completed his post-doc training at the University of Adelaide in Australia, Dr. Li was appointed as assistant professor in the Department of Medicine, Loma Linda University in 1999. From 2001-2007, Dr. Li was a Senior research Professional (PI) and Director of Functional Genomics facility at the University of Chicago. He joined the UCLA faculty in 2007 as Professor of genomics. Dr. Li's research focuses on the identification and characterization of genetic variations that affect complex diseases. He uses an integrated genomic approach to investigate global mRNA/miRNA expression, copy number variation, single nucleotide polymorphism and DNA-protein interaction by primarily using microarray-based technologies for initial screening and siRNA/miRNA-mediated technologies for functional screening. His ultimate goal is to identify genetic variations of clinical importance.

Talks

Spatial Transcriptomics: Technologies, Applications and Experimental Considerations

07 May 2023, 03:00 PM
Prof. Xinmin Li

Junshi Biosciences

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics.

Hemosure

We at Hemosure are proud to manufacture and sell the fastest-growing Immunological Fecal Immunochemical Test (FIT) and have established its place as an industry leader.

Incyte

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Want to sponsor this event? Contact Us